- Home
- PSQH vs PLRX Comparison
PSQH vs PLRX Comparison
Compare PSQH & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSQH
- PLRX
- Stock Information
- Founded
- PSQH 2021
- PLRX 2015
- Country
- PSQH United States
- PLRX United States
- Employees
- PSQH N/A
- PLRX N/A
- Industry
- PSQH Advertising
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- PSQH Consumer Discretionary
- PLRX Health Care
- Exchange
- PSQH Nasdaq
- PLRX Nasdaq
- Market Cap
- PSQH 76.2M
- PLRX 89.0M
- IPO Year
- PSQH N/A
- PLRX 2020
- Fundamental
- Price
- PSQH $2.09
- PLRX $1.46
- Analyst Decision
- PSQH Strong Buy
- PLRX Hold
- Analyst Count
- PSQH 2
- PLRX 10
- Target Price
- PSQH $6.00
- PLRX $3.93
- AVG Volume (30 Days)
- PSQH 1.1M
- PLRX 692.5K
- Earning Date
- PSQH 11-11-2025
- PLRX 11-06-2025
- Dividend Yield
- PSQH N/A
- PLRX N/A
- EPS Growth
- PSQH N/A
- PLRX N/A
- EPS
- PSQH N/A
- PLRX N/A
- Revenue
- PSQH $27,580,806.00
- PLRX N/A
- Revenue This Year
- PSQH $23.05
- PLRX N/A
- Revenue Next Year
- PSQH $58.10
- PLRX N/A
- P/E Ratio
- PSQH N/A
- PLRX N/A
- Revenue Growth
- PSQH 93.83
- PLRX N/A
- 52 Week Low
- PSQH $1.55
- PLRX $1.10
- 52 Week High
- PSQH $7.77
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- PSQH 61.60
- PLRX 40.86
- Support Level
- PSQH $1.95
- PLRX $1.66
- Resistance Level
- PSQH $2.16
- PLRX $1.85
- Average True Range (ATR)
- PSQH 0.12
- PLRX 0.12
- MACD
- PSQH 0.06
- PLRX -0.03
- Stochastic Oscillator
- PSQH 87.93
- PLRX 2.27
About PSQH PSQ Holdings Inc.
PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.